Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | ADTN | AGNT |
|---|---|---|
| Price | $7.76 | $3.79 |
| Change today | ▲ 1.84% | ▼ 0.92% |
| Market cap | $632.30M | $632.54M |
| Return, 3 months | -42.7% | -20.9% |
| Return, year to date | -10.7% | -57.0% |
| Return, 1 year | -14.6% | -64.1% |
| P/E (TTM) | -27.7 | -37.9 |
| P/B | 4.9 | 2.3 |
| P/E percentile vs own 5y | 26th | 27th |
| Dividend yield | – | 5.28% |
| Revenue growth (YoY, latest qtr) | +6.1% | +10.7% |
| Net profit growth (YoY) | +52.3% | -17.5% |
| Gross margin | 38.5% | 6.8% |
| Operating margin | -0.2% | -0.2% |
| Net margin | -1.9% | -0.3% |
| Return on equity | -14.7% | -6.9% |
| Analyst target vs. price | +89.0% | +42.1% |
| Analyst buy share | 100% | 33% |
| RSI (14) | 57 | 48 |
| 30-day volatility | 50.1% | 55.8% |
| Max drawdown, 1 year | -64.9% | -69.4% |
| Trend read | Leaning bullish | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
